| Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), 143-152, 2013 | 18969* | 2013 |
| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 R Lozano, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, ... The lancet 380 (9859), 2095-2128, 2012 | 12160 | 2012 |
| Heart disease and stroke statistics-2017 update: a report from the American Heart Association. EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, J Floyd, ... Circulation 135 (10), e146-e603, 2017 | 7972 | 2017 |
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy BM Brenner, ME Cooper, D De Zeeuw, WF Keane, WE Mitch, HH Parving, ... New England journal of medicine 345 (12), 861-869, 2001 | 7855 | 2001 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 7802 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 6329 | 2012 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 4677* | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The Lancet 386 (9995), 743-800, 2015 | 3629 | 2015 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The Lancet 388 (10053), 1545-1602, 2016 | 3022* | 2016 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … II Abubakar, T Tillmann, A Banerjee Lancet 385 (9963), 117-171, 2015 | 2806 | 2015 |
| Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Blood Pressure Lowering Treatment Trialists' Collaboration The Lancet 362 (9395), 1527-1535, 2003 | 2646 | 2003 |
| American heart association statistics committee and stroke statistics subcommittee EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... Heart disease and stroke statistics-2017 update: a report from the American …, 2017 | 2152* | 2017 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 1907 | 2016 |
| A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ... New England Journal of Medicine 361 (21), 2019-2032, 2009 | 1842 | 2009 |
| Von Willebrand factor–cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome M Furlan, R Robles, M Galbusera, G Remuzzi, PA Kyrle, B Brenner, ... New England Journal of Medicine 339 (22), 1578-1584, 1998 | 1835 | 1998 |
| Rosuvastatin and cardiovascular events in patients undergoing hemodialysis BC Fellström, AG Jardine, RE Schmieder, H Holdaas, K Bannister, ... New England Journal of Medicine 360 (14), 1395-1407, 2009 | 1813 | 2009 |
| Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ... The Lancet 390 (10100), 1151-1210, 2017 | 1759 | 2017 |
| Pathophysiology of progressive nephropathies G Remuzzi, T Bertani New England Journal of Medicine 339 (20), 1448-1456, 1998 | 1614 | 1998 |
| Delirium in elderly people SK Inouye, RGJ Westendorp, JS Saczynski The Lancet 383 (9920), 911-922, 2014 | 1611 | 2014 |
| Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Gisen Group The Lancet 349 (9069), 1857-1863, 1997 | 1311 | 1997 |
